external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus.
Explore the latest updates from the life science industry.

PHARMA

EyePoint’s DURAVYU misses first Phase 3 endpoint in wet AMD, putting focus on second trial

EyePoint says an unusual imbalance in unrelated vision loss affected LUGANO results, while secondary data point to reduced treatment burden.

Featured Articles.

PHARMA

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma

BIOTECH

Using Jumping Genes for Safer, More Accurate DNA Editing

BIOTECH

Tecan Brings Agentic AI to the Lab Bench with NVIDIA-powered Introspect Upgrade

PHARMA

Sanofi halts amlitelimab development for atopic dermatitis following pipeline review

HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

BIOTECH

Moving research out of the lab is key to UK life science success

PHARMA

How Automation is Accelerating Drug Discovery Timelines

BIOPROCESSING

Bioreactors and Cell Culture Media: A Practical Comparison for Upstream Bioprocessing

PHARMA

AI in Science Writing and the Imitation of Understanding

Latest News.

25th August, 2026

01. Carterra HT-SPR Helps Turn Anthropic’s Autonomous Protein Design Into Measurable Results

Carterra’s high-throughput SPR platforms help validate 1,320 AI-designed protein binders across 15 targets, highlighting the growing role of rapid experimental data in AI-driven drug discovery.

18th August, 2026

02. EyePoint’s DURAVYU misses first Phase 3 endpoint in wet AMD, putting focus on second trial

EyePoint says an unusual imbalance in unrelated vision loss affected LUGANO results, while secondary data point to reduced treatment burden.

17th August, 2026

03. Tagomics launches cfDNA platform for multi-organ drug safety monitoring

Cambridge-based precision medicine company introduces LiquiPath to support earlier detection of treatment-related toxicity across the drug development lifecycle.